ijms-logo

Journal Browser

Journal Browser

Obesity and Arterial Hypertensionis

A special issue of International Journal of Molecular Sciences (ISSN 1422-0067). This special issue belongs to the section "Molecular Endocrinology and Metabolism".

Deadline for manuscript submissions: closed (31 May 2022) | Viewed by 6453

Special Issue Editor


E-Mail Website
Guest Editor

Special Issue Information

Dear Colleagues,

The world is currently faced with obesity, growing as a disease across all demographics of the human population. This is manifested by an increase in body weight due to an excess amount of adipose tissue and a violation of metabolic processes throughout the body. Very often, abdominal obesity contributes to the development of various pathologies, among which arterial hypertension occurs most often. This combination is capable of leading to various vascular disorders that cause decreased work ability, disability and life expectancy.

Numerous studies have shown that obesity and arterial hypertension can provoke one another and aggravate the course of their development. It has been shown that an important role is played by the development of oxidative stress, damage to the vascular endothelium, disruption of receptor apparatus, and sometimes the development of insulin resistance. At the same time, the subtle molecular mechanisms of the development of obesity and arterial hypertension are still in the plane of scientific discussion. Their disclosure will allow for a new look at the pathogenesis of the isolated and combined occurrence of arterial hypertension and obesity. This can help to further improve approaches to the prevention and treatment of obesity and arterial hypertension.

Existing approaches to the treatment of obesity and arterial hypertension are currently being developed in detail. The possibilities of various options for correcting the dietary regimen and the effect of physical activity have been studied, as have the various schemes of drug exposure, with a large number of drugs being known. At the same time, due to insufficient knowledge of the molecular mechanisms of the formation of obesity and arterial hypertension and an incomplete understanding of the effect of the treatment used on these mechanisms, the problem of these two diseases is still very urgent. This Special Issue attempts to present the latest advances in obesity and hypertension research. In this regard, clinical observations and experimental studies performed at the molecular level on the issue of this issue are encouraged.

Prof. Dr. Ilya Nikolaevich Medvedev
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • obesity
  • arterial hypertension
  • vascular wall
  • treatment with organoprotection
  • prevention of thrombosis
  • non-drug treatment

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

26 pages, 437 KiB  
Review
Hypertension Related to Obesity: Pathogenesis, Characteristics and Factors for Control
by Paul El Meouchy, Mohamad Wahoud, Sabine Allam, Roy Chedid, Wissam Karam and Sabine Karam
Int. J. Mol. Sci. 2022, 23(20), 12305; https://doi.org/10.3390/ijms232012305 - 14 Oct 2022
Cited by 22 | Viewed by 6095
Abstract
The World Health Organization (WHO) refers to obesity as abnormal or excessive fat accumulation that presents a health risk. Obesity was first designated as a disease in 2012 and since then the cost and the burden of the disease have witnessed a worrisome [...] Read more.
The World Health Organization (WHO) refers to obesity as abnormal or excessive fat accumulation that presents a health risk. Obesity was first designated as a disease in 2012 and since then the cost and the burden of the disease have witnessed a worrisome increase. Obesity and hypertension are closely interrelated as abdominal obesity interferes with the endocrine and immune systems and carries a greater risk for insulin resistance, diabetes, hypertension, and cardiovascular disease. Many factors are at the interplay between obesity and hypertension. They include hemodynamic alterations, oxidative stress, renal injury, hyperinsulinemia, and insulin resistance, sleep apnea syndrome and the leptin-melanocortin pathway. Genetics, epigenetics, and mitochondrial factors also play a major role. The measurement of blood pressure in obese patients requires an adapted cuff and the search for other secondary causes is necessary at higher thresholds than the general population. Lifestyle modifications such as diet and exercise are often not enough to control obesity, and so far, bariatric surgery constitutes the most reliable method to achieve weight loss. Nonetheless, the emergence of new agents such as Semaglutide and Tirzepatide offers promising alternatives. Finally, several molecular pathways are actively being explored, and they should significantly extend the treatment options available. Full article
(This article belongs to the Special Issue Obesity and Arterial Hypertensionis)
Back to TopTop